Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 15451793)

1.

ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver.

Parini P, Davis M, Lada AT, Erickson SK, Wright TL, Gustafsson U, Sahlin S, Einarsson C, Eriksson M, Angelin B, Tomoda H, Omura S, Willingham MC, Rudel LL.

Circulation. 2004 Oct 5;110(14):2017-23. Epub 2004 Sep 27.

2.

Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis.

Rudel LL, Lee RG, Cockman TL.

Curr Opin Lipidol. 2001 Apr;12(2):121-7. Review.

PMID:
11264983
3.

Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2.

Chang TY, Chang CC, Lin S, Yu C, Li BL, Miyazaki A.

Curr Opin Lipidol. 2001 Jun;12(3):289-96. Review.

PMID:
11353332
4.

ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia.

Rudel LL, Lee RG, Parini P.

Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1112-8. Epub 2005 Apr 14. Review.

5.

Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.

Leon C, Hill JS, Wasan KM.

Pharm Res. 2005 Oct;22(10):1578-88. Epub 2005 Sep 22. Review.

PMID:
16180116
6.

Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.

Burnett JR, Wilcox LJ, Huff MW.

Clin Chim Acta. 1999 Aug;286(1-2):231-42. Review.

PMID:
10511295
7.

Acyl-coenzyme A:cholesteryl acyltransferase 2.

Joyce C, Skinner K, Anderson RA, Rudel LL.

Curr Opin Lipidol. 1999 Apr;10(2):89-95. Review.

PMID:
10327276
8.

Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.

Tomoda H, Doi T.

Acc Chem Res. 2008 Jan;41(1):32-9. Epub 2007 Sep 6. Review.

PMID:
17803269
9.

Acyl-coenzyme A:cholesterol acyltransferases.

Chang TY, Li BL, Chang CC, Urano Y.

Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E1-9. doi: 10.1152/ajpendo.90926.2008. Epub 2009 Jan 13. Review.

10.

Acyl coenzyme A:cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic drugs.

Alegret M, Llaverias G, Silvestre JS.

Methods Find Exp Clin Pharmacol. 2004 Sep;26(7):563-86. Review.

PMID:
15538545
11.

Mammalian acyl-CoA:cholesterol acyltransferases.

Buhman KF, Accad M, Farese RV.

Biochim Biophys Acta. 2000 Dec 15;1529(1-3):142-54. Review.

PMID:
11111084
12.

Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?

López-Farré AJ, Sacristán D, Zamorano-León JJ, San-Martín N, Macaya C.

Cardiovasc Ther. 2008 Spring;26(1):65-74. doi: 10.1111/j.1527-3466.2007.00030.x. Review.

PMID:
18466422
13.

Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.

Miyazaki A, Sakai M, Sakamoto Y, Horiuchi S.

Curr Opin Investig Drugs. 2003 Sep;4(9):1095-9. Review.

PMID:
14582454
14.

Isoform-specific inhibitors of ACATs: recent advances and promising developments.

Ohshiro T, Tomoda H.

Future Med Chem. 2011 Dec;3(16):2039-61. doi: 10.4155/fmc.11.158. Review.

PMID:
22098352
15.

Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis.

Chang C, Dong R, Miyazaki A, Sakashita N, Zhang Y, Liu J, Guo M, Li BL, Chang TY.

Acta Biochim Biophys Sin (Shanghai). 2006 Mar;38(3):151-6. Review.

16.

Catalysis of ACAT may be completed within the plane of the membrane: a working hypothesis.

Chang TY, Chang CC, Lu X, Lin S.

J Lipid Res. 2001 Dec;42(12):1933-8. Review.

17.

Inhibitors of acyl-coenzyme a: cholesterol acyltransferase.

Miyazaki A, Kanome T, Watanabe T.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):463-9. Review.

PMID:
16503866
18.

[Roles of acyl-coenzyme A: cholesterol acyltransferase (ACAT) isozymes].

Miyazaki A, Horiuchi S.

Tanpakushitsu Kakusan Koso. 1999 Jun;44(8 Suppl):1312-8. Review. Japanese. No abstract available.

PMID:
10397022
19.

[Acyl-coenzyme A: cholesterol acyltransferase (ACAT)].

Miyazaki A, Watanabe T.

Nihon Rinsho. 2004 Dec;62 Suppl 12:89-91. Review. Japanese. No abstract available.

PMID:
15658270
20.

Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms.

Tomoda H, Omura S.

Pharmacol Ther. 2007 Sep;115(3):375-89. Epub 2007 May 31. Review.

PMID:
17614133
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk